MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,310 | -93.7% | 12,347 | -84.1% | 0.00% | – |
| Q2 2023 | $116,342 | +78.2% | 77,561 | +104.3% | 0.00% | – |
| Q1 2023 | $65,303 | -69.4% | 37,967 | -79.6% | 0.00% | – |
| Q4 2022 | $213,550 | -71.3% | 185,695 | -34.9% | 0.00% | – |
| Q3 2022 | $745,000 | -57.9% | 285,461 | -65.0% | 0.00% | – |
| Q2 2022 | $1,771,000 | -58.2% | 816,318 | -10.2% | 0.00% | -100.0% |
| Q1 2022 | $4,234,000 | +12.2% | 908,576 | +45.8% | 0.00% | – |
| Q4 2021 | $3,775,000 | -21.5% | 623,034 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $4,811,000 | +6.9% | 668,151 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $4,500,000 | – | 714,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NorthRock Partners, LLC | 1,354,004 | $9,749,000 | 0.80% |
| Shay Capital LLC | 197,184 | $1,420,000 | 0.18% |
| Corundum Group, Inc. | 11,240 | $81,000 | 0.06% |
| Mirae Asset Global Investments Co., Ltd. | 1,132,131 | $8,151,000 | 0.02% |
| Patriot Financial Group Insurance Agency, LLC | 500 | $4,000 | 0.00% |
| MORGAN STANLEY | 668,151 | $4,811,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,956 | $21,000 | 0.00% |
| NORTHERN TRUST CORP | 56,561 | $407,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 279 | $2,000 | 0.00% |